Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,816 | -32,900 | -29,697 | -17,039 | -5,395 |
| Depreciation Amortization | 443 | 2,614 | 2,171 | 1,437 | 710 |
| Accounts receivable | N/A | N/A | -1,530 | N/A | -500 |
| Accounts payable and accrued liabilities | -1,064 | 357 | -741 | 221 | -812 |
| Other Working Capital | -1,757 | 7,600 | 5,975 | 1,206 | -1,886 |
| Other Operating Activity | 1,386 | 7,505 | 12,162 | 3,665 | 2,760 |
| Operating Cash Flow | $-4,808 | $-14,824 | $-11,660 | $-10,510 | $-5,123 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -63,307 | -59,532 | N/A | N/A |
| PPE Investments | -6 | -585 | -453 | -243 | -161 |
| Investing Cash Flow | $-6 | $-63,892 | $-59,985 | $-243 | $-161 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -8 | -961 | -4,770 | -437 | 122 |
| Beginning Cash Position | 157,306 | 236,983 | 236,983 | 236,983 | 236,983 |
| End Cash Position | 152,484 | 157,306 | 160,568 | 225,793 | 231,821 |
| Net Cash Flow | $-4,822 | $-79,677 | $-76,415 | $-11,190 | $-5,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,808 | -14,824 | -11,660 | -10,510 | -5,123 |
| Capital Expenditure | -6 | -585 | -453 | -243 | -161 |
| Free Cash Flow | -4,814 | -15,409 | -12,113 | -10,753 | -5,284 |